Liver Neoplasms

Home
About
Help
History (1)
- Liver Neoplasms
- See All Pages

"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the LIVER.

Descriptor ID	D008113
MeSH Number(s)	C04.588.274.623 C06.301.623 C06.552.697
Concept/Terms	Liver Neoplasms Liver Neoplasms Neoplasms, Hepatic Neoplasms, Liver Liver Neoplasm Neoplasm, Liver Hepatic Neoplasms Hepatic Neoplasm Neoplasm, Hepatic Cancer of Liver Cancer of Liver Hepatocellular Cancer Cancers, Hepatocellular Hepatocellular Cancers Hepatic Cancer Cancer, Hepatic Cancers, Hepatic Hepatic Cancers Liver Cancer Cancer, Liver Cancers, Liver Liver Cancers Cancer of the Liver Cancer, Hepatocellular

Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Liver Neoplasms [C04.588.274.623]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Liver Neoplasms [C06.301.623]
Liver Diseases [C06.552]
Liver Neoplasms [C06.552.697]

Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.

Bar chart showing 169 publications over 28 distinct years, with a maximum of 15 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	0	1
1994	2	0	2
1997	1	0	1
1998	2	0	2
1999	3	1	4
2000	1	0	1
2001	3	0	3
2003	1	1	2
2004	1	0	1
2005	4	2	6
2006	2	1	3
2007	5	1	6
2008	7	1	8
2009	8	2	10
2010	4	2	6
2011	6	0	6
2012	5	1	6
2013	6	4	10
2014	4	1	5
2015	14	1	15
2016	11	2	13
2017	12	2	14
2018	7	3	10
2019	3	3	6
2020	6	1	7
2021	7	2	9
2022	7	1	8
2023	4	0	4

Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.

Rasic G, de Geus SWL, Beaulieu-Jones B, Kasumova GG, Kent TS, Ng SC, McAneny D, Tseng JF, Sachs TE. A nationwide propensity score analysis comparing ablation and resection for hepatocellular carcinoma. J Surg Oncol. 2023 Jun; 127(7):1125-1134.

View in: PubMed
Vreeland TJ, Collings AT, Ozair A, Adams AM, Dirks R, Kushner BS, Sucandy I, Morrell D, Whiteside J, Ansari MT, Cloyd J, Cleary SP, Ceppa E, Abou-Setta AM, Alseidi A, Awad Z, Ayloo S, Buell J, Orthopoulos G, Richardson W, Sbayi S, Wakabayashi G, Asbun H, Slater BJ, Pryor AD, Jeyarajah DR. SAGES/AHPBA guidelines for the use of minimally invasive surgery for the surgical treatment of colorectal liver metastases (CRLM). Surg Endosc. 2023 04; 37(4):2508-2516.

View in: PubMed
Nandivada P, Tirabassi M. Invited Commentary: Persistence Pays Off- Pursuing NED Status in Hepatoblastoma Improves Survival: An Observational Study by Fleming A, et?al. J Pediatr Surg. 2023 Jun; 58(6):1088-1089.

View in: PubMed
Mou H, Eskiocak O, ?zler KA, Gorman M, Yue J, Jin Y, Wang Z, Gao Y, Janowitz T, Meyer HV, Yu T, Wilkinson JE, Kucukural A, Ozata DM, Beyaz S. CRISPR-induced exon skipping of ?-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer. J Pathol. 2023 04; 259(4):415-427.

View in: PubMed
Papageorge MV, de Geus SWL, Woods AP, Ng SC, Lee S, McAneny D, Tseng JF, Kenzik K, Sachs TE. ASO Visual Abstract: Surveillance Patterns for Hepatocellular Carcinoma Among Screening-Eligible Patients in the Medicare Population. Ann Surg Oncol. 2022 12; 29(13):8434-8435.

View in: PubMed
Ozair A, Collings A, Adams AM, Dirks R, Kushner BS, Sucandy I, Morrell D, Abou-Setta AM, Vreeland T, Whiteside J, Cloyd JM, Ansari MT, Cleary SP, Ceppa E, Richardson W, Alseidi A, Awad Z, Ayloo S, Buell JF, Orthopoulos G, Sbayi S, Wakabayashi G, Slater BJ, Pryor A, Jeyarajah DR. Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis. Surg Endosc. 2022 Nov; 36(11):7915-7937.

View in: PubMed
Papageorge MV, de Geus SWL, Woods AP, Ng SC, Lee S, McAneny D, Tseng JF, Kenzik KM, Sachs TE. Surveillance Patterns for Hepatocellular Carcinoma among Screening-Eligible Patients in the Medicare Population. Ann Surg Oncol. 2022 Dec; 29(13):8424-8431.

View in: PubMed
Schneider KM, Mohs A, Gui W, Galvez EJC, Candels LS, Hoenicke L, Muthukumarasamy U, Holland CH, Elfers C, Kilic K, Schneider CV, Schierwagen R, Strnad P, Wirtz TH, Marschall HU, Latz E, Lelouvier B, Saez-Rodriguez J, de Vos W, Strowig T, Trebicka J, Trautwein C. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment. Nat Commun. 2022 07 08; 13(1):3964.

View in: PubMed
Hickman TL, Choi E, Whiteman KR, Muralidharan S, Pai T, Johnson T, Parikh A, Friedman T, Gilbert M, Shen B, Barron L, McGinness KE, Ettenberg SA, Motz GT, Weiss GJ, Jensen-Smith A. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity. PLoS One. 2022; 17(5):e0266980.

View in: PubMed
Rizzo A, Mollica V, Santoni M, Ricci AD, Gadaleta-Caldarola G, Montironi R, Massari F. Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis. Future Oncol. 2022 Feb; 18(6):739-748.

View in: PubMed

People

Explore

Similar Concepts

Top Journals